Cassava Sciences Inc. (NASDAQ:SAVA) trading with an addition of $1.63 to $56.62 on Thursday, an upside of 2.96 percent. An average of 2,689,479 shares of common stock have been traded in the last five days. There was a gain of $3.23 in the past week, and it reached a new high 16 times over the past 12 months. The last 20 days have seen an average of 6,859,945 shares traded, while the 50-day average volume stands at 8,377,958.
SAVA stock has increased by 31.59% in the last month. The company shares reached their 1-month lowest point of $39.01 on 09/15/21. With the stock rallying to its 52-week high on 07/29/21, shares of the company touched a low of $6.70 and a high of $146.16 in 52 weeks. It has reached a new high 19 times so far this year and achieved 706.30% or $50.03 in price. In spite of this, the price is down -61.26% from the 52-week high.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
The quick ratio of Cassava Sciences Inc. for the three months ended June 29 was 60.30, and the current ratio was 60.30, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the quarter ending June 29.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Cassava Sciences Inc.’s return on assets was -7.40%, compared to -42.3% over the last five years. Meanwhile, the return on equity (ROE) for the past 12 months has been -7.50% and the 5-year average holds at -44.8%. For the broader industry, ROE averaged -68.79 over the past year.
The company posted a net income of -$5.13 million in the quarter, while revenues of -$3.53 million were grew 77.78%. The analyst consensus anticipated Cassava Sciences Inc.’s latest quarter earnings to come in at -$0.13 per share, but it turned out to be -$0.13, a 0.00% surprise. Shareholders own equity worth $40.02 million.
From a technical analysis perspective, let’s take a brief look at Cassava Sciences Inc. (SAVA) price momentum. RSI 9-day as of the close on 13 October was 52.51%, suggesting the stock is Neutral, with historical volatility in this time frame at 88.55%.
As of today, SAVA’s price is $53.26 +6.02% or $3.23 from its 5-day moving average. SAVA is currently trading +29.35% higher than its 20-day SMA and +17.75% higher than its 100-day SMA. However, the stock’s current price level is -35.59% below the SMA50 and +737.26% above the SMA200.
The stochastic %K and %D were 30.22% and 22.99%, respectively, and the average true range (ATR) was 5.60. With the 14-day stochastic at 40.34% and the average true range at 6.47, the RSI (14) stands at 48.14%. The stock has reached 0.81 on the 9-day MACD Oscillator while the 14-day reading was at -2.72.
Cantor Fitzgerald downgraded Cassava Sciences Inc. (NASDAQ: SAVA) to a a Neutral rating in its most recent analyst report. Previously, the stock was rated as a an Overweight.The consensus rating for Cassava Sciences Inc. (SAVA) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell SAVA, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 4 others rate it as a “buy”.
What is SAVA’s price target for the next 12 months?
Analysts predict a range of price targets between $108.00 and $215.00, with a median target of $124.00. Taking a look at these predictions, the average price target given by analysts for Cassava Sciences Inc. (SAVA) stock is $149.20.